| Wed, Jul 8, 2009 | | | FDA orders Sepracor to halt Lunesta trials at bizjournals.com (Wed, Jul 8)
| | Thu, Jul 2, 2009 | | | [$$] Rite Aid Drops 12%, and Dynegy Loses 6% at The Wall Street Journal Online (Thu, Jul 2)
| | | [$$] Stocks in the Spotlight Thursday at Barron's Online (Thu, Jul 2)
| | | Elan, NRG Energy, Boeing are big movers AP (Thu, Jul 2)
| | | MoneyGram Int'l, Sepracor: Biggest Price Decliners (MGI, SEPR) at The Wall Street Journal Online (Thu, Jul 2)
| | | Study of Sepracors Depression Drug Has Investors Gloomy at Seeking Alpha (Thu, Jul 2)
| | | Sepracor's depression candidate disappoints at bizjournals.com (Thu, Jul 2)
| | | Sepracor slides on trial failure and Lunesta halt AP (Thu, Jul 2)
| | | Sepracor downgraded by Deutsche Securities Briefing.com (Thu, Jul 2)
| | Wed, Jul 1, 2009 | | | [video] Sepracor Faces Setbacks at Forbes.com (Wed, Jul 1)
| | | UPDATE - Two Sepracor drugs suffer setback, shares tumble at Reuters (Wed, Jul 1)
| | | SEPRACOR INC /DE/ Files SEC form 8-K, Other Events EDGAR Online (Wed, Jul 1)
| | | Sepracor Provides Update on Clinical Trials for SEP-225289 and LUNESTA® Pediatrics Business Wire (Wed, Jul 1)
| | Thu, Jun 18, 2009 | | | [video] 3 Stocks I Saw on TV TheStreet.com TV (Thu, Jun 18)
| | Wed, Jun 17, 2009 | | | Watson Pharma to buy Arrow group for $1.75B AP (Wed, Jun 17)
| | | Cramer's 'Mad Money' Follow-Up: Sepracor at TheStreet.com (Wed, Jun 17)
| | | Watson to go global with $1.75 billion Arrow buy Reuters (Wed, Jun 17)
| | | UPDATE - Watson to go global with $1.75 billion Arrow buy at Reuters (Wed, Jun 17)
| | | [video] Mad Money Post Game: Healthcare Trade at TheStreet.com (Wed, Jun 17)
| | | [video] 3 Stocks I Saw on TV at TheStreet.com (Wed, Jun 17)
| Add SEPR News to My Yahoo!:

| |
|